-
New treatments for neurogenic detrusor overactivity
Gabriele Gaziev, Valerio Iacovelli, Luca Topazio, Daniele Bianchi & Enrico Finazzi Agro
Clinical Trail Outcomes: Clinical Investigation
-
New treatments for neurogenic detrusor overactivity
Gabriele Gaziev, Valerio Iacovelli, Luca Topazio, Daniele Bianchi & Enrico Finazzi Agro
Clinical Trail Outcomes: Clinical Investigation
-
New treatments for neurogenic detrusor overactivity
Gabriele Gaziev, Valerio Iacovelli, Luca Topazio, Daniele Bianchi & Enrico Finazzi Agro
Clinical Trail Outcomes: Clinical Investigation
-
New treatments for neurogenic detrusor overactivity
Gabriele Gaziev, Valerio Iacovelli, Luca Topazio, Daniele Bianchi & Enrico Finazzi Agro
Clinical Trail Outcomes: Clinical Investigation
-
New treatments for neurogenic detrusor overactivity
Gabriele Gaziev, Valerio Iacovelli, Luca Topazio, Daniele Bianchi & Enrico Finazzi Agro
Clinical Trail Outcomes: Clinical Investigation
-
New treatments for neurogenic detrusor overactivity
Gabriele Gaziev, Valerio Iacovelli, Luca Topazio, Daniele Bianchi & Enrico Finazzi Agro
Clinical Trail Outcomes: Clinical Investigation
-
New treatments for neurogenic detrusor overactivity
Gabriele Gaziev, Valerio Iacovelli, Luca Topazio, Daniele Bianchi & Enrico Finazzi Agro
Clinical Trail Outcomes: Clinical Investigation
-
New treatments for neurogenic detrusor overactivity
Gabriele Gaziev, Valerio Iacovelli, Luca Topazio, Daniele Bianchi & Enrico Finazzi Agro
Clinical Trail Outcomes: Clinical Investigation
-
Estimating site costs prior to conducting clinical trials
Dorothee Arenz, Barbara Hero, Barbara F Eichhorst, Martin Langer, Lars Pester, Julia von Tresckow, Jrg J Vehreschild, Maria JGT Vehreschild, Oliver A Cornely
Special Report: Clinical Investigation
-
Estimating site costs prior to conducting clinical trials
Dorothee Arenz, Barbara Hero, Barbara F Eichhorst, Martin Langer, Lars Pester, Julia von Tresckow, Jrg J Vehreschild, Maria JGT Vehreschild, Oliver A Cornely
Special Report: Clinical Investigation
-
Estimating site costs prior to conducting clinical trials
Dorothee Arenz, Barbara Hero, Barbara F Eichhorst, Martin Langer, Lars Pester, Julia von Tresckow, Jrg J Vehreschild, Maria JGT Vehreschild, Oliver A Cornely
Special Report: Clinical Investigation
-
Estimating site costs prior to conducting clinical trials
Dorothee Arenz, Barbara Hero, Barbara F Eichhorst, Martin Langer, Lars Pester, Julia von Tresckow, Jrg J Vehreschild, Maria JGT Vehreschild, Oliver A Cornely
Special Report: Clinical Investigation
-
Estimating site costs prior to conducting clinical trials
Dorothee Arenz, Barbara Hero, Barbara F Eichhorst, Martin Langer, Lars Pester, Julia von Tresckow, Jrg J Vehreschild, Maria JGT Vehreschild, Oliver A Cornely
Special Report: Clinical Investigation
-
Estimating site costs prior to conducting clinical trials
Dorothee Arenz, Barbara Hero, Barbara F Eichhorst, Martin Langer, Lars Pester, Julia von Tresckow, Jrg J Vehreschild, Maria JGT Vehreschild, Oliver A Cornely
Special Report: Clinical Investigation
-
Estimating site costs prior to conducting clinical trials
Dorothee Arenz, Barbara Hero, Barbara F Eichhorst, Martin Langer, Lars Pester, Julia von Tresckow, Jrg J Vehreschild, Maria JGT Vehreschild, Oliver A Cornely
Special Report: Clinical Investigation
-
Estimating site costs prior to conducting clinical trials
Dorothee Arenz, Barbara Hero, Barbara F Eichhorst, Martin Langer, Lars Pester, Julia von Tresckow, Jrg J Vehreschild, Maria JGT Vehreschild, Oliver A Cornely
Special Report: Clinical Investigation
-
New advances in the diagnosis and treatment of pediatric tuberculosis
Andrea T Cruz, Anna M Mandalakas
Review: Clinical Trail Outcomes: Clinical Investigation
-
New advances in the diagnosis and treatment of pediatric tuberculosis
Andrea T Cruz, Anna M Mandalakas
Review: Clinical Trail Outcomes: Clinical Investigation
-
New advances in the diagnosis and treatment of pediatric tuberculosis
Andrea T Cruz, Anna M Mandalakas
Review: Clinical Trail Outcomes: Clinical Investigation
-
New advances in the diagnosis and treatment of pediatric tuberculosis
Andrea T Cruz, Anna M Mandalakas
Review: Clinical Trail Outcomes: Clinical Investigation
-
New advances in the diagnosis and treatment of pediatric tuberculosis
Andrea T Cruz, Anna M Mandalakas
Review: Clinical Trail Outcomes: Clinical Investigation
-
New advances in the diagnosis and treatment of pediatric tuberculosis
Andrea T Cruz, Anna M Mandalakas
Review: Clinical Trail Outcomes: Clinical Investigation
-
New advances in the diagnosis and treatment of pediatric tuberculosis
Andrea T Cruz, Anna M Mandalakas
Review: Clinical Trail Outcomes: Clinical Investigation
-
New advances in the diagnosis and treatment of pediatric tuberculosis
Andrea T Cruz, Anna M Mandalakas
Review: Clinical Trail Outcomes: Clinical Investigation
-
The emerging role of vedolizumab in the treatment of ulcerative colitis
Mahmoud H Mosli, Brian G Feagan
Review: Clinical Trail Outcomes: Clinical Investigation
-
The emerging role of vedolizumab in the treatment of ulcerative colitis
Mahmoud H Mosli, Brian G Feagan
Review: Clinical Trail Outcomes: Clinical Investigation
-
The emerging role of vedolizumab in the treatment of ulcerative colitis
Mahmoud H Mosli, Brian G Feagan
Review: Clinical Trail Outcomes: Clinical Investigation
-
The emerging role of vedolizumab in the treatment of ulcerative colitis
Mahmoud H Mosli, Brian G Feagan
Review: Clinical Trail Outcomes: Clinical Investigation
-
The emerging role of vedolizumab in the treatment of ulcerative colitis
Mahmoud H Mosli, Brian G Feagan
Review: Clinical Trail Outcomes: Clinical Investigation
-
The emerging role of vedolizumab in the treatment of ulcerative colitis
Mahmoud H Mosli, Brian G Feagan
Review: Clinical Trail Outcomes: Clinical Investigation
-
The emerging role of vedolizumab in the treatment of ulcerative colitis
Mahmoud H Mosli, Brian G Feagan
Review: Clinical Trail Outcomes: Clinical Investigation
-
The emerging role of vedolizumab in the treatment of ulcerative colitis
Mahmoud H Mosli, Brian G Feagan
Review: Clinical Trail Outcomes: Clinical Investigation
-
Immunotherapy & cancer - making the past prologue Immunotherapeutic combinations for cancer
Susan F Slovin
Review: Clinical Trail Outcomes: Clinical Investigation
-
Immunotherapy & cancer - making the past prologue Immunotherapeutic combinations for cancer
Susan F Slovin
Review: Clinical Trail Outcomes: Clinical Investigation
-
Immunotherapy & cancer - making the past prologue Immunotherapeutic combinations for cancer
Susan F Slovin
Review: Clinical Trail Outcomes: Clinical Investigation
-
Immunotherapy & cancer - making the past prologue Immunotherapeutic combinations for cancer
Susan F Slovin
Review: Clinical Trail Outcomes: Clinical Investigation
-
Immunotherapy & cancer - making the past prologue Immunotherapeutic combinations for cancer
Susan F Slovin
Review: Clinical Trail Outcomes: Clinical Investigation
-
Immunotherapy & cancer - making the past prologue Immunotherapeutic combinations for cancer
Susan F Slovin
Review: Clinical Trail Outcomes: Clinical Investigation
-
Immunotherapy & cancer - making the past prologue Immunotherapeutic combinations for cancer
Susan F Slovin
Review: Clinical Trail Outcomes: Clinical Investigation
-
Immunotherapy & cancer - making the past prologue Immunotherapeutic combinations for cancer
Susan F Slovin
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging therapies for head and neck cancer: review of the Phase II and III trials
Nicole G Chau, Bonnie S Glisson
Review Article: Clinical Investigation
-
Emerging therapies for head and neck cancer: review of the Phase II and III trials
Nicole G Chau, Bonnie S Glisson
Review Article: Clinical Investigation
-
Emerging therapies for head and neck cancer: review of the Phase II and III trials
Nicole G Chau, Bonnie S Glisson
Review Article: Clinical Investigation
-
Emerging therapies for head and neck cancer: review of the Phase II and III trials
Nicole G Chau, Bonnie S Glisson
Review Article: Clinical Investigation
-
Emerging therapies for head and neck cancer: review of the Phase II and III trials
Nicole G Chau, Bonnie S Glisson
Review Article: Clinical Investigation
-
Emerging therapies for head and neck cancer: review of the Phase II and III trials
Nicole G Chau, Bonnie S Glisson
Review Article: Clinical Investigation
-
Emerging therapies for head and neck cancer: review of the Phase II and III trials
Nicole G Chau, Bonnie S Glisson
Review Article: Clinical Investigation
-
Emerging therapies for head and neck cancer: review of the Phase II and III trials
Nicole G Chau, Bonnie S Glisson
Review Article: Clinical Investigation